Related Experiment Videos

Amyloid-beta-induced chemokine production in primary human macrophages and astrocytes

Hessel A Smits1, Annemarie Rijsmus, Joyce H van Loon

  • 1Section Neuroimmunology, Eijkman-Winkler Institute for Microbiology, Infectious Diseases and Inflammation, University Medical Center Utrecht, Heidelberglaan 100, NL-3584 CX Utrecht, The Netherlands.

Insights

Alzheimer's disease (AD) involves amyloid-beta (Abeta) stimulating glial cells. Macrophages and astrocytes produce inflammatory signals (MIP-1alpha, MIP-1beta, MCP-1) in response to Abeta, contributing to AD pathogenesis.

Area of Science:

  • Neuroscience
  • Immunology
  • Cell Biology

Background:

  • Chemotaxis of glial cells towards neuritic plaques is implicated in Alzheimer's disease (AD) pathogenesis.
  • Amyloid-beta (Abeta) is a key component of neuritic plaques in AD.

Purpose of the Study:

  • To investigate the role of amyloid-beta (Abeta) in stimulating glial cell chemokine production.
  • To model the chemotactic response of macrophages and astrocytes to Abeta in Alzheimer's disease.

Main Methods:

  • Primary monocyte-derived macrophages and adult astrocytes were used as cellular models.
  • Cells were stimulated with amyloid-beta (Abeta) (1-42).
  • Messenger RNA (mRNA) and protein levels of chemokines (MIP-1alpha, MIP-1beta, MCP-1) were measured using RT-PCR and ELISA.

Main Results:

  • Amyloid-beta (Abeta) stimulated the production of MIP-1alpha and MIP-1beta mRNA in macrophages.
  • Amyloid-beta (Abeta) stimulated the production of MCP-1 mRNA in astrocytes.
  • Both mRNA and protein levels of these chemokines increased in stimulated macrophages, astrocytes, and cocultures.

Conclusions:

  • Amyloid-beta (Abeta) directly stimulates macrophages and astrocytes to produce chemokines involved in glial cell recruitment.
  • These findings support a role for Abeta-induced chemotaxis in the inflammatory response observed in Alzheimer's disease.

Related Concept Videos